First Time Loading...

PainChek Ltd
ASX:PCK

Watchlist Manager
PainChek Ltd Logo
PainChek Ltd
ASX:PCK
Watchlist
Price: 0.03 AUD 3.45% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

PCK's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

PainChek Ltd. engages in the development and commercialisation of mobile medical device applications. [ Read More ]

The intrinsic value of one PCK stock under the Base Case scenario is 0.004 AUD. Compared to the current market price of 0.03 AUD, PainChek Ltd is Overvalued by 87%.

Key Points:
PCK Intrinsic Value
Base Case
0.004 AUD
Overvaluation 87%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
PainChek Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PCK stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
PainChek Ltd

Provide an overview of the primary business activities
of PainChek Ltd.

What unique competitive advantages
does PainChek Ltd hold over its rivals?

What risks and challenges
does PainChek Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for PainChek Ltd.

Provide P/S
for PainChek Ltd.

Provide P/E
for PainChek Ltd.

Provide P/OCF
for PainChek Ltd.

Provide P/FCFE
for PainChek Ltd.

Provide P/B
for PainChek Ltd.

Provide EV/S
for PainChek Ltd.

Provide EV/GP
for PainChek Ltd.

Provide EV/EBITDA
for PainChek Ltd.

Provide EV/EBIT
for PainChek Ltd.

Provide EV/OCF
for PainChek Ltd.

Provide EV/FCFF
for PainChek Ltd.

Provide EV/IC
for PainChek Ltd.

Show me price targets
for PainChek Ltd made by professional analysts.

What are the Revenue projections
for PainChek Ltd?

How accurate were the past Revenue estimates
for PainChek Ltd?

What are the Net Income projections
for PainChek Ltd?

How accurate were the past Net Income estimates
for PainChek Ltd?

What are the EPS projections
for PainChek Ltd?

How accurate were the past EPS estimates
for PainChek Ltd?

What are the EBIT projections
for PainChek Ltd?

How accurate were the past EBIT estimates
for PainChek Ltd?

Compare the revenue forecasts
for PainChek Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of PainChek Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of PainChek Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of PainChek Ltd compared to its peers.

Compare the P/E ratios
of PainChek Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing PainChek Ltd with its peers.

Analyze the financial leverage
of PainChek Ltd compared to its main competitors.

Show all profitability ratios
for PainChek Ltd.

Provide ROE
for PainChek Ltd.

Provide ROA
for PainChek Ltd.

Provide ROIC
for PainChek Ltd.

Provide ROCE
for PainChek Ltd.

Provide Gross Margin
for PainChek Ltd.

Provide Operating Margin
for PainChek Ltd.

Provide Net Margin
for PainChek Ltd.

Provide FCF Margin
for PainChek Ltd.

Show all solvency ratios
for PainChek Ltd.

Provide D/E Ratio
for PainChek Ltd.

Provide D/A Ratio
for PainChek Ltd.

Provide Interest Coverage Ratio
for PainChek Ltd.

Provide Altman Z-Score Ratio
for PainChek Ltd.

Provide Quick Ratio
for PainChek Ltd.

Provide Current Ratio
for PainChek Ltd.

Provide Cash Ratio
for PainChek Ltd.

What is the historical Revenue growth
over the last 5 years for PainChek Ltd?

What is the historical Net Income growth
over the last 5 years for PainChek Ltd?

What is the current Free Cash Flow
of PainChek Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for PainChek Ltd.

Financials

Balance Sheet Decomposition
PainChek Ltd

Current Assets 3.7m
Cash & Short-Term Investments 2m
Receivables 1.6m
Other Current Assets 131.1k
Non-Current Assets 23.6k
PP&E 23.6k
Current Liabilities 2.5m
Accounts Payable 2.2m
Other Current Liabilities 281.3k
Efficiency

Earnings Waterfall
PainChek Ltd

Revenue
2.5m AUD
Cost of Revenue
-1.5m AUD
Gross Profit
962.9k AUD
Operating Expenses
-8.7m AUD
Operating Income
-7.8m AUD
Other Expenses
-10 AUD
Net Income
-7.8m AUD

Free Cash Flow Analysis
PainChek Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PCK Profitability Score
Profitability Due Diligence

PainChek Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional ROIC
Exceptional 1-Year Revenue Growth
ROIC is Increasing
28/100
Profitability
Score

PainChek Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

PCK Solvency Score
Solvency Due Diligence

PainChek Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
50/100
Solvency
Score

PainChek Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PCK Price Targets Summary
PainChek Ltd

Wall Street analysts forecast PCK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PCK is 0.08 AUD .

Lowest
Price Target
Not Available
Average
Price Target
0.08 AUD
167% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

PCK Price
PainChek Ltd

1M 1M
+7%
6M 6M
-30%
1Y 1Y
+11%
3Y 3Y
-55%
5Y 5Y
-12%
10Y 10Y
-85%
Annual Price Range
0.03
52w Low
0.024
52w High
0.059
Price Metrics
Average Annual Return 82.5%
Standard Deviation of Annual Returns 251.14%
Max Drawdown -93%
Shares Statistics
Market Capitalization 49.1m AUD
Shares Outstanding 1 635 830 000
Percentage of Shares Shorted
N/A

PCK Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

PainChek Ltd Logo
PainChek Ltd

Country

Australia

Industry

Health Care

Market Cap

49.1m AUD

Dividend Yield

0%

Description

PainChek Ltd. engages in the development and commercialisation of mobile medical device applications. The company is headquartered in Sydney, New South Wales. The company went IPO on 2012-05-01. The Company’s principal activities are development and commercialization of mobile medical device applications, that automate intelligent pain assessment of individuals who are unable to communicate their pain with carers. Its Paincheck is an Adult and Infant pain assessment applications. Its PainChek technology uses cameras in smartphones and tablets to capture a brief video of the person, which is analyzed in real time using facial recognition software to detect the presence of facial micro-expressions that are indicative of the presence of pain. Its Paincheck uses artificial intelligence (AI) to automatically assess the micro-facial features of pain. Its PainChek technology has multiple regulatory clearances, including TGA (Australia) and CE Mark (Europe) for use as a class 1 medical device to assess pain in people who are unable to reliably verbalize, such people with dementia.

Contact

NEW SOUTH WALES
Sydney
SE 401 35 Lime St
+1800098809.0
http://www.painchek.com

IPO

2012-05-01

Employees

-

Officers

MD, CEO & Director
Mr. Philip Daffas B.Sc., Dip EENG, GAICD, M.B.A.
Chief Financial Officer
Mr. Iain McAdam
Manager & Head of Operations
Mr. Andrew Hoggan
Chief Technology Officer
Mr. Scott Robertson M.B.A.
Chief Scientific Officer
Prof. Jeff Hughes Ph.D.
Head of Business Development
Mr. David Allsopp
Show More
Company Secretary
Ms. Natalie Climo
Show Less

See Also

Discover More
What is the Intrinsic Value of one PCK stock?

The intrinsic value of one PCK stock under the Base Case scenario is 0.004 AUD.

Is PCK stock undervalued or overvalued?

Compared to the current market price of 0.03 AUD, PainChek Ltd is Overvalued by 87%.